MDM2 and lymphoma: MDM2 amplification and overexpression are found at a high frequency in soft tissue tumours, e.g., liposarcoma, at a lower frequency in glioblastoma and breast cancer, but not in tumour types like leukaemia, lymphoma, and melanoma.